Alkermes Stock Analysis

ALKS -  USA Stock  

USD 25.56  1.56  6.50%

The latest Alkermes Plc price fall could raise concerns from retail investors as the firm it trading at a share price of 25.56 on 1,697,998 in volume. The company directors and management were unable to exploit market volatilities in December. However, diversifying your overall positions with Alkermes Plc can protect your principal portfolio during market swings. The stock standard deviation of daily returns for 90 days investing horizon is currently 3.26. The above-average risk is mostly attributed to market volatility and speculations regarding some of the upcoming earning calls from Alkermes Plc partners.
Please continue to Trending Equities.

Alkermes Stock Analysis 

The Alkermes Plc stock analysis report makes it easy to digest most publicly released information about Alkermes Plc and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Alkermes Stock analysis module also helps to analyze the Alkermes Plc price relationship with some important fundamental indicators such as market cap and management efficiency.

Alkermes Stock Analysis Notes

About 97.0% of the company shares are held by institutions such as insurance companies. The book value of Alkermes Plc was presently reported as 6.78. The company has Price/Earnings To Growth (PEG) ratio of 0.34. Alkermes Plc recorded a loss per share of 0.57. The entity had not issued any dividends in recent years. The firm had 2:1 split on the 15th of May 2000. Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Alkermes plc was founded in 1987 and is headquartered in Dublin, Ireland. Alkermes Plc operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 2245 people. For more info on Alkermes Plc please contact Richard Pops at 353 1 772 8000 or go to

Alkermes Plc Quarterly Cost of Revenue

49.56 MillionShare

Alkermes Plc Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Alkermes Plc's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Alkermes Plc or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Alkermes Plc generated a negative expected return over the last 90 days
Alkermes Plc has high historical volatility and very poor performance
The company reported the previous year's revenue of 1.13 B. Net Loss for the year was (91.68 M) with profit before overhead, payroll, taxes, and interest of 860.44 M.
Over 97.0% of the company shares are held by institutions such as insurance companies
Latest headline from featured highlights include Alkermes, Tesla, Nucor Corp. and GoPro - Entrepreneur

Alkermes Plc Upcoming and Recent Events

Earnings reports are used by Alkermes Plc to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Alkermes Plc previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report10th of February 2022
Next Earnings Report27th of April 2022
Next Fiscal Quarter End31st of December 2021
Next Fiscal Year End10th of February 2022
Last Quarter Report30th of September 2021
Last Earning Announcement31st of December 2020

Alkermes Largest EPS Surprises

Earnings surprises can significantly impact Alkermes Plc's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Fiscal Date
Estimated EPS
Reported EPS
View All Earnings Estimates

Alkermes Plc SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Alkermes Plc prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Alkermes Plc investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Alkermes Plc specific information freely available to individual and institutional investors to make a timely investment decision.
11th of January 2022
Financial Statements and Exhibits. Other Events. Regulation FD Disclosure
10th of January 2022
Unclassified Corporate Event
19th of November 2021
Financial Statements and Exhibits. Regulation FD Disclosure. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Unclassified Corporate Event
8th of November 2021
Financial Statements and Exhibits. Regulation FD Disclosure. Termination of a Material Definitive Agreement
27th of October 2021
Financial Statements and Exhibits. Results of Operations and Financial Condition
10th of September 2021
Unclassified Corporate Event. Unclassified Corporate Event
28th of July 2021
Financial Statements and Exhibits. Results of Operations and Financial Condition
12th of July 2021
Unclassified Corporate Event

Alkermes Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Alkermes Plc is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Alkermes Plc backward and forwards among themselves. Alkermes Plc's institutional investor refers to the entity that pools money to purchase Alkermes Plc's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Russell Investments Group LtdCommon Shares339.7 K7.9 M
Diversified Trust CoCommon Shares24 K558 K
Integrated Investment Consultants LlcCommon Shares11.9 K278 K
Trust Co Of VermontCommon Shares100023 K
Whittier Trust CoCommon Shares41510 K
Baillie Gifford CoCommon Shares192K
Spire Wealth ManagementCommon Shares118K
Note, although Alkermes Plc's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Alkermes Market Capitalization

The company currently falls under 'Mid-Cap' category with current market capitalization of 4.04 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Alkermes Plc's market, we take the total number of its shares issued and multiply it by Alkermes Plc's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Alkermes Profitablity

Alkermes Plc's profitability indicators refer to fundamental financial ratios that showcase Alkermes Plc's ability to generate income relative to its revenue or operating costs. If, let's say, Alkermes Plc is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Alkermes Plc's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Alkermes Plc's profitability requires more research than a typical breakdown of Alkermes Plc's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (8.12) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (5.53) %, which suggests for every $100 dollars of sales, it generated a net operating loss of -0.06.
Last ReportedProjected for 2022
Return on Average Assets(0.05) (0.06) 
Return on Average Equity(0.09) (0.10) 
Return on Invested Capital(0.05) (0.06) 
Return on Sales(0.1) (0.10) 

Management Efficiency

The entity has return on total asset (ROA) of (2.01) % which means that it has lost $2.01 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (8.41) %, meaning that it created substantial loss on money invested by shareholders. Alkermes Plc management efficiency ratios could be used to measure how well alkermes plc manages its routine affairs as well as how well it operates its assets and liabilities. As of 01/24/2022, Return on Average Assets is likely to drop to -0.06. In addition to that, Return on Average Equity is likely to drop to -0.1. Alkermes Plc Assets Non Current are relatively stable at the moment as compared to the past year. Alkermes Plc reported last year Assets Non Current of 964.57 Million. As of 01/24/2022, Goodwill and Intangible Assets is likely to grow to about 279.9 M, while Total Assets are likely to drop slightly above 2.1 B.
Last ReportedProjected for 2022
Book Value per Share 7.73  8.36 
Enterprise Value over EBIT(43.70) (47.15) 
Enterprise Value over EBITDA(495.98) (509.03) 
Price to Book Value 3.42  4.59 
Tangible Assets Book Value per Share 12.64  11.56 
Enterprise Value3.8 B5.3 B
Tangible Asset ValueB1.8 B

Technical Drivers

As of the 24th of January, Alkermes Plc shows the mean deviation of 2.05, and Risk Adjusted Performance of (0.08). Alkermes Plc technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to collect data for nineteen technical drivers for Alkermes Plc, which can be compared to its rivals. Please confirm Alkermes Plc information ratio, as well as the relationship between the potential upside and kurtosis to decide if Alkermes Plc is priced correctly, providing market reflects its regular price of 25.56 per share. Given that Alkermes Plc has jensen alpha of (0.31), we suggest you to validate Alkermes Plc's prevailing market performance to make sure the company can sustain itself at a future point.

Alkermes Plc Price Movement Analysis

The output start index for this execution was thirty-two with a total number of output elements of twenty-nine. The MESA Adaptive Moving Average indicator adapts to Alkermes Plc price movement based on the rate change of phase as measured by the Hilbert Transform Discriminator. View also all equity analysis or get more info about mesa adaptive moving average overlap studies indicator.

Alkermes Plc Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Alkermes Plc insiders, such as employees or executives, is commonly permitted as long as it does not rely on Alkermes Plc's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Alkermes Plc insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Laurencin Cato T over a month ago via Macroaxis 
Acquisition by Laurencin Cato T of 237 shares of Alkermes Plc subject to Rule 16b-3
Gaynor Richard over a month ago via Macroaxis 
Exercise or conversion by Gaynor Richard of 5578 shares of Alkermes Plc subject to Rule 16b-3
Shane Cooke over three months ago via Macroaxis 
Acquisition by Shane Cooke of 15677 shares of Alkermes Plc subject to Rule 16b-3
Jackson Blair Curtis over three months ago via Macroaxis 
Payment of 2024 shares by Jackson Blair Curtis of Alkermes Plc subject to Rule 16b-3
Iain Brown over three months ago via Macroaxis 
Exercise or conversion by Iain Brown of 40000 shares of Alkermes Plc subject to Rule 16b-3
Mckeon Brian P over three months ago via Macroaxis 
Purchase by Mckeon Brian P of 10000 shares of Alkermes Plc
David Gaffin over three months ago via Macroaxis 
Exercise or conversion by David Gaffin of 14000 shares of Alkermes Plc subject to Rule 16b-3
David Anstice over six months ago via Macroaxis 
Exercise or conversion by David Anstice of 20000 shares of Alkermes Plc subject to Rule 16b-3
Alva Emily Peterson over six months ago via Macroaxis 
Acquisition by Alva Emily Peterson of 15677 shares of Alkermes Plc subject to Rule 16b-3
Alva Emily Peterson over six months ago via Macroaxis 
Acquisition by Alva Emily Peterson of 22759 shares of Alkermes Plc subject to Rule 16b-3
Nichols Christian Todd over six months ago via Macroaxis 
Exercise or conversion by Nichols Christian Todd of 3500 shares of Alkermes Plc subject to Rule 16b-3
Gaynor Richard over six months ago via Macroaxis 
Exercise or conversion by Gaynor Richard of 6104 shares of Alkermes Plc subject to Rule 16b-3

Alkermes Plc Predictive Daily Indicators

Alkermes Plc intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Alkermes Plc stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Alkermes Plc Forecast Models

Alkermes Plc time-series forecasting models is one of many Alkermes Plc's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Alkermes Plc's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Alkermes Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Alkermes Plc stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Alkermes shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Alkermes Plc. By using and applying Alkermes Stock analysis, traders can create a robust methodology for identifying Alkermes entry and exit points for their positions.
Last ReportedProjected for 2022
EBITDA Margin(0.0054) (0.005826) 
Gross Margin 0.95  0.95 
Profit Margin(0.12) (0.13) 
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Alkermes plc was founded in 1987 and is headquartered in Dublin, Ireland. Alkermes Plc operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 2245 people.

Current Alkermes Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Alkermes analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Alkermes analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
Alkermes Plc current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Alkermes analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Alkermes stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Alkermes Plc, talking to its executives and customers, or listening to Alkermes conference calls.
Alkermes Analyst Advice Details

Alkermes Stock Analysis Indicators

Alkermes Plc stock analysis indicators help investors evaluate how Alkermes Plc stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Alkermes Plc shares will generate the highest return on investment. By understating and applying Alkermes Plc stock analysis, traders can identify Alkermes Plc position entry and exit signals to maximize returns.
Quick Ratio1.88
Fifty Two Week Low18.02
Revenue Growth11.00%
Shares Short Prior Month11.37M
Average Daily Volume Last 10 Day1.3M
Average Daily Volume In Three Month1.16M
Shares Percent Shares Out8.07%
Gross Margins83.47%
Short Percent Of Float11.24%
Forward Price Earnings58.14
Float Shares145.79M
Fifty Two Week High33.00
Enterprise Value To Ebitda251.37
Fifty Day Average23.60
Two Hundred Day Average25.61
Enterprise Value To Revenue3.44
Please continue to Trending Equities. Note that the Alkermes Plc information on this page should be used as a complementary analysis to other Alkermes Plc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Complementary Tools for Alkermes Stock analysis

When running Alkermes Plc price analysis, check to measure Alkermes Plc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alkermes Plc is operating at the current time. Most of Alkermes Plc's value examination focuses on studying past and present price action to predict the probability of Alkermes Plc's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Alkermes Plc's price. Additionally, you may evaluate how the addition of Alkermes Plc to your portfolios can decrease your overall portfolio volatility.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Equity Valuation
Check real value of public entities based on technical and fundamental data
Bond Directory
Find actively traded corporate debentures issued by US companies
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Is Alkermes Plc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alkermes Plc. If investors know Alkermes will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alkermes Plc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Alkermes Plc is measured differently than its book value, which is the value of Alkermes that is recorded on the company's balance sheet. Investors also form their own opinion of Alkermes Plc's value that differs from its market value or its book value, called intrinsic value, which is Alkermes Plc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alkermes Plc's market value can be influenced by many factors that don't directly affect Alkermes Plc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alkermes Plc's value and its price as these two are different measures arrived at by different means. Investors typically determine Alkermes Plc value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alkermes Plc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.